Part I: consensus statements and expert recommendations for HER2-negative early breast cancer in the Asia-Pacific region: diagnosis and risk assessment by Soo Chin Lee, Yeon Hee Park, Christian F. Singer, Judith Balmaña, Rebecca Alexandra Dent, Veronique Kiak-Mien Tan, Nadia Ayu Mulansari, Mastura Md Yusof, Frances Victoria F. Que, Yen-Shen Lu, Napa Parinyanitikul, Cam Phuong Pham, Nur Aishah Taib, Sun-Young Kong, Yoland Antill, Yoland Antill, Hee Jeong Kim

Get full text

Part II: consensus statements and expert recommendations for BRCA-associated breast cancer in the Asia-Pacific region: clinical management by Yeon Hee Park, Soo Chin Lee, Christian F. Singer, Judith Balmaña, Rebecca Alexandra Dent, Veronique Kiak-Mien Tan, Nadia Ayu Mulansari, Mastura Md. Yusof, Frances Victoria F. Que, Yen-Shen Lu, Napa Parinyanitikul, Cam Phuong Pham, Cam Phuong Pham, Cam Phuong Pham, Nur Aishah Taib, Sun-Young Kong, Yoland Antill, Yoland Antill, Hee Jeong Kim

Get full text

Clinical activity of durvalumab for patients with advanced mismatch repair-deficient and repair-proficient endometrial cancer. A nonrandomized phase 2 clinical trial by Linda Mileshkin, Elizabeth Barnes, Tarek Meniawy, Kristy Robledo, Michael Friedlander, Geraldine Goss, Jermaine Coward, Yoland Antill, Michelle Cummins, Sally Baron-Hay, Martin R Stockler, Catherine Shannon, Philip Beale, Peey-Sei Kok, Deborah Smith, Sonia Yip, Amanda Spurdle, Yeh Chen Lee, Janine Lombard, John Andrews

Get full text